These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38257138)

  • 1. Safety and Suitability of Infant Formula Manufactured from Extensively Hydrolyzed Whey Protein Compared to Intact Protein: A Combined Analysis of Two Randomized Controlled Studies.
    Fleddermann M; Knoll A; Koletzko B
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Suitability of an Infant Formula Manufactured from Extensively Hydrolysed Protein in Healthy Term Infants.
    Otten L; Schelker E; Petersen H; Nomayo A; Fleddermann M; Arendt BM; Britzl T; Haberl EM; Jochum F;
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial.
    Picaud JC; Pajek B; Arciszewska M; Tarczón I; Escribano J; Porcel R; Adelt T; Hassink E; Rijnierse A; Abrahamse-Berkeveld M; Korczowski B; On Behalf Of The Tenuto Study Group
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32668666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Partially Hydrolyzed Whey Infant Formula Supports Appropriate Growth: A Randomized Controlled Non-Inferiority Trial.
    Karaglani E; Thijs-Verhoeven I; Gros M; Chairistanidou C; Zervas G; Filoilia C; Kampani TM; Miligkos V; Matiatou M; Valaveri S; Sakellariou A; Babilis G; Bos R; Manios Y
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33036201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of infants consuming whey-predominant term infant formulas with a protein content of 1.8 g/100 kcal: a multicenter pooled analysis of individual participant data.
    Alexander DD; Yan J; Bylsma LC; Northington RS; Grathwohl D; Steenhout P; Erdmann P; Spivey-Krobath E; Haschke F
    Am J Clin Nutr; 2016 Oct; 104(4):1083-1092. PubMed ID: 27604774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolyzed Formula With Reduced Protein Content Supports Adequate Growth: A Randomized Controlled Noninferiority Trial.
    Ahrens B; Hellmuth C; Haiden N; Olbertz D; Hamelmann E; Vusurovic M; Fleddermann M; Roehle R; Knoll A; Koletzko B; Wahn U; Beyer K
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):822-830. PubMed ID: 29216020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application effect of extensively hydrolyzed milk protein formula and follow-up in preterm children with a gestational age of less than 34 weeks: study protocol for a randomized controlled trial.
    Yin LP; Qian LJ; Zhu H; Chen Y; Li H; Han JN; Qiao LX
    Trials; 2015 Nov; 16():498. PubMed ID: 26537897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth, Gastrointestinal Tolerance and Stool Characteristics of Healthy Term Infants Fed an Infant Formula Containing Hydrolyzed Whey Protein (63%) and Intact Casein (37%): A Randomized Clinical Trial.
    Wu SL; Ding D; Fang AP; Chen PY; Chen S; Jing LP; Chen YM; Zhu HL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29144393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants.
    Rigo J; Schoen S; Verghote M; van Overmeire B; Marion W; Abrahamse-Berkeveld M; Alliet P
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31331065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustainable clinical research, health economic aspects and medical marketing: drivers of product innovation.
    Haschke F; Klassen-Wigger P
    Nestle Nutr Workshop Ser Pediatr Program; 2010; 66():125-41. PubMed ID: 20664221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A follow-up study of nutrient intake, nutritional status, and growth in infants with cow milk allergy fed either a soy formula or an extensively hydrolyzed whey formula.
    Seppo L; Korpela R; Lönnerdal B; Metsäniitty L; Juntunen-Backman K; Klemola T; Paganus A; Vanto T
    Am J Clin Nutr; 2005 Jul; 82(1):140-5. PubMed ID: 16002812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.
    Osborn DA; Sinn J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003664. PubMed ID: 17054180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term effects of feeding hydrolyzed protein infant formulas on growth at < or = 6 y of age: results from the German Infant Nutritional Intervention Study.
    Rzehak P; Sausenthaler S; Koletzko S; Reinhardt D; von Berg A; Krämer U; Berdel D; Bollrath C; Grübl A; Bauer CP; Wichmann HE; Heinrich J;
    Am J Clin Nutr; 2009 Jun; 89(6):1846-56. PubMed ID: 19369380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life.
    Turck D; Grillon C; Lachambre E; Robiliard P; Beck L; Maurin JL; Kempf C; Bernet JP; Marx J; Lebrun F; Van Egroo LD
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):364-71. PubMed ID: 16954961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Tolerance of an Infant Formula Manufactured from Extensively Hydrolysed Protein in Healthy Term Infants.
    Otten L; Schelker E; Petersen H; Nomayo A; Conzade R; Günther J; Grieger A; Jochum F; On Behalf Of The Hasi Study Group
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V.
    ; Bohn T; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Bresson JL; Castle L; Fewtrell M; Przyrembel H; Dumas C; Titz A; Turck D
    EFSA J; 2023 Jul; 21(7):e08063. PubMed ID: 37469354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile colic: crying time reduction with a whey hydrolysate: A double-blind, randomized, placebo-controlled trial.
    Lucassen PL; Assendelft WJ; Gubbels JW; van Eijk JT; Douwes AC
    Pediatrics; 2000 Dec; 106(6):1349-54. PubMed ID: 11099588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study.
    Halken S; Hansen KS; Jacobsen HP; Estmann A; Faelling AE; Hansen LG; Kier SR; Lassen K; Lintrup M; Mortensen S; Ibsen KK; Osterballe O; Høst A
    Pediatr Allergy Immunol; 2000 Aug; 11(3):149-61. PubMed ID: 10981524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmed Hypoallergenicity of a Novel Whey-Based Extensively Hydrolyzed Infant Formula Containing Two Human Milk Oligosaccharides.
    Nowak-Wegrzyn A; Czerkies L; Reyes K; Collins B; Heine RG
    Nutrients; 2019 Jun; 11(7):. PubMed ID: 31248026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.